Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic…

Overview of attention for article published in Ophthalmology Retina, May 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,165 followers.

RT @RodolfoJGalindo: SGLT2i a/w lower risk of sight-threatening DM retinopathy c/w other glucose-lowering therapies. GLP1a not confer inc…

SGLT2i a/w lower risk of sight-threatening DM retinopathy c/w other glucose-lowering therapies. GLP1a not confer increased retinal risk, c/w to DPP-4i and sulfonylureas While waiting for FOCUS trial @RozalinaMD @JoshuaNeumiller @PCORI https://t.co/…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.